tns: Novartis "rankea" en Europa y Merck en USA...

-->

Click en imagen para ampliar...

NEW YORK, NEW YORK, February 17, 2009—New TNS Healthcare research

shows that physicians in four out of the five major European countries—the UK,

Germany, Spain and Italy—give Novartis top marks for effectively delivering key

sales and service activities. Merck takes the top spot in the US and ties with

Novartis in the UK and Germany. In 2008, Merck and Novartis tied for the top

spot in the US, with the highest ratings across all service activities. This year,

Merck pulls ahead in the US, with stronger ratings for both its web-based

physician services and its patient information programs.

Pfizer, AstraZeneca, Sanofi-Aventis and GlaxoSmithKline also earn high marks

for their service model from physicians across the US and Europe. Pfizer and

GlaxoSmithKline tie for second place in the US, pulling ahead of Novartis, which

places third this year among American doctors. In addition, Pfizer ties for first

place in the UK and Germany. GlaxoSmithKline also is among the companies

tying for a first place finish in the UK. It ties with Novartis for top honors in Italy.

Sanofi-Aventis leads all of its competitors in France, becoming the sole first-place winner. It also ties for the top spot in the UK and Germany.